Pharmaceutical Flooring Installation

Drug-manufacturing facilities subject to FDA current good manufacturing practice requirements must support cleaning, maintenance and proper operations. For aseptic processing, 21 CFR 211.42 addresses smooth, hard, easily cleanable room surfaces as appropriate.

The facility’s quality team defines the applicable room and flooring requirements. Choosing a resinous flooring system alone does not establish compliance or sterile conditions.

We review process chemicals, solvents, detergents and disinfectants with their concentrations, temperatures and contact times. Include products used together or in sequence, along with routine cleaning and decontamination procedures. Repeated sanitation exposure belongs in the selection review alongside accidental spills.

Craftsman confirms compatibility for the proposed flooring, joint materials and adjoining details against those conditions.

We select texture according to wet or dry conditions, likely spills, footwear and cleaning methods. A more pronounced profile can affect both traction and the effort needed to remove contamination. The project team agrees the required finish and any specified evaluation before installation.

Craftsman considers polished concrete only for assessed dry, noncritical areas where an exposed slab suits the use. Polished concrete remains porous; acids can etch it and some spills can leave stains.

Our commercial polished concrete installation service includes slab evaluation and an approval mockup to establish the attainable appearance, including existing repairs and natural variation.

Required coves, corners and the sealed connection to the wall system.

Drainage, connections to the flooring and termination details.

Sealed connections, changes in height and adjoining flooring systems. A continuous topcoat across different systems requires an approved compatible assembly.

Treatments that accommodate expected movement and suit the traffic and chemical exposure.

A seamless resinous floor still needs movement joints where the slab or building components move. Covering those joints with a rigid coating does not remove their function.

The substrate must be clean, sound and prepared to the manufacturer’s required profile, with moisture conditions acceptable for that system. When moisture testing is included in our scope, Craftsman employees perform it and issue a written report. Results are evaluated against the project criteria and system requirements.

Where results fall outside those limits, we determine whether further evaluation or a separately approved mitigation scope is needed. Additional work discovered during preparation is documented, with changes to scope, cost and schedule resolved before installation continues.

Dust capture, barriers, air management, housekeeping and separate crew or material routes are selected for the work and adjacent use. Activities requiring closure or restricted access are identified before installation begins.

Each work window includes preparation, installation, applicable curing, inspection or specified testing, and cleanup. The project plan establishes return-to-service requirements and who authorizes each area to reopen.

Closeout documentation includes the system documents, test and installation reports, corrective-work and acceptance records, and care instructions required by the project.

Every direct Craftsman test produces a written digital report. Mapped locations, conditions, photographs, criteria and pass/fail reporting are included when specified. Third-party testing or inspection is coordinated where assigned.

Request a pharmaceutical flooring proposal with the location, room uses, approximate area by room and plans or photographs. Include process and cleaning chemicals, existing floor conditions, required coves and drains, acceptance documents and available shutdown windows.

For adjoining areas with other uses, review our flooring applications by industry.